.png)
Lisa Gurry is the Chief Business Officer at GeneDx, where she is leading the company through its next phase of growth – advancing data and information services across biopharma, health systems, and other partners – to accelerate the future of precision medicine.
In this role, Lisa drives GeneDx’s strategic business operations and partnership models, unlocking the full potential of GeneDx Infinity™, the largest rare disease dataset. She also oversees the company’s communications function and collaborates on market growth strategies. Learn more about Lisa and her leadership role at GeneDx.
Insights from
Lisa Gurry
Connecting genomic data with real-world evidence has the power to transform rare disease research and accelerate therapeutic development. By linking comprehensive datasets like GeneDx Infinity™ with longitudinal patient insights, healthcare and biopharma stakeholders can better understand disease progression, improve clinical trial design, and ultimately get the right treatments to patients faster.